CARLSBAD, Calif., July 21, 2022 — CB Therapeutics (the “Company”), a biosynthesis company focused on creating ethically-produced, environmentally-friendly products for human health, has successfully developed various food tech prototypes using its next-gen synbio and precision fermentation platform. Now, the Company is looking for partnerships in the food technology and active ingredient spaces that align with its value propositions.
Among them is the ability to produce ingredients cost-effectively with a minimal carbon footprint. In addition, the Company is procuring partnerships and collaborations to implement new scalable manufacturing methods for its customers’ products. As an innovation hub, CB Therapeutics’ solutions have also enabled it to rapidly grow its IP portfolio in very competitive fields, such as psychedelics and cannabinoid biosynthesis, bioinformatics, and other technologies.
“We’ve developed a powerful, fast, and portable platform for generating a wide range of ingredients and products. We have a strong precedent in the nutraceutical and clinical research spaces from our cannabinoid and psychedelic medicine work. Still, our platform can tackle even wider supply chain issues sustainably,” says Dr. Jacob Vogan, CSO of CB Therapeutics. “We’ve prototyped the generation of animal-free proteins, fats, colorants, flavors, aromas, and much more in the lab through scalable precision fermentation.”
“This is an exhilarating time for biotech and biomanufacturing. We have the personnel and equipment needed for the bioidentical, animal-free production of proteins, peptides, fats, flavor compounds, and vitamins traditionally found in animal-based foods. Our process also enables improved products such as de-allerginizing proteins and peptides, or enriching products with vitamins, antioxidants, and other health-promoting nutrients,” says CEO Sher Ali Butt.
Why is food technology a hot trend right now?
- Sustainability over energy-consuming means of food production.
- The benefits to human health at an affordable price.
- Celebrities like JayZ, Ashton Kutcher and Leonardo DiCaprio are actively investing in food technology ventures.
Top three food technologies CB Therapeutics is excited about
- Alternative animal products—alternatives to dairy, meat and seafood.
- Food products that can be enriched with nutrients and aromas.
- Cheeses!—Cheese composition and associated microorganisms.
About CB Therapeutics
CB Therapeutics produces high-value molecules, compounds, and rare ingredients from simple sugars utilizing yeast and the process of fermentation. Since its inception, CB Therapeutics has developed standardized biotechnology processes for producing natural molecules and their analogs for clinical research in psychedelic medicine, cannabinoid-based therapies, and food technologies. As a drug discovery platform with the ability to create a clean and secure supply of products, The Company’s partnership allows it to develop custom production process technologies to support and scale drug product manufacturing to meet clinical patient supply demands. In turn, this enables partners to move more swiftly through clinical development.
CB Therapeutics’ expertise in synthetic genomics and bio-engineering has significantly advanced its proprietary production platform of microorganisms, enzymes, and production processes. After more than four years of research and development, the CB Therapeutics team can produce a broad range of phytochemicals faster, utilizing fewer resources, at greater yields, and with more purity, consistency, and efficiency than competing platforms. CB Therapeutics operates from their new 16,000 sq. ft. fully-licensed commercial batch facility in southern California.
Dir. of Communications, Alan Aldous Inc.
Business Development Lead, CB Therapeutics
Follow CB Therapeutics on Twitter: @CBTherapeutics
Follow CB Therapeutics on Instagram: @cbthera